Read us | Listen to us | Watch us | Join Live Events | Turn Off Ads | Live |

Click on your language to translate this article:

Afrikaans Afrikaans Albanian Albanian Amharic Amharic Arabic Arabic Armenian Armenian Azerbaijani Azerbaijani Basque Basque Belarusian Belarusian Bengali Bengali Bosnian Bosnian Bulgarian Bulgarian Catalan Catalan Cebuano Cebuano Chichewa Chichewa Chinese (Simplified) Chinese (Simplified) Chinese (Traditional) Chinese (Traditional) Corsican Corsican Croatian Croatian Czech Czech Danish Danish Dutch Dutch English English Esperanto Esperanto Estonian Estonian Filipino Filipino Finnish Finnish French French Frisian Frisian Galician Galician Georgian Georgian German German Greek Greek Gujarati Gujarati Haitian Creole Haitian Creole Hausa Hausa Hawaiian Hawaiian Hebrew Hebrew Hindi Hindi Hmong Hmong Hungarian Hungarian Icelandic Icelandic Igbo Igbo Indonesian Indonesian Irish Irish Italian Italian Japanese Japanese Javanese Javanese Kannada Kannada Kazakh Kazakh Khmer Khmer Korean Korean Kurdish (Kurmanji) Kurdish (Kurmanji) Kyrgyz Kyrgyz Lao Lao Latin Latin Latvian Latvian Lithuanian Lithuanian Luxembourgish Luxembourgish Macedonian Macedonian Malagasy Malagasy Malay Malay Malayalam Malayalam Maltese Maltese Maori Maori Marathi Marathi Mongolian Mongolian Myanmar (Burmese) Myanmar (Burmese) Nepali Nepali Norwegian Norwegian Pashto Pashto Persian Persian Polish Polish Portuguese Portuguese Punjabi Punjabi Romanian Romanian Russian Russian Samoan Samoan Scottish Gaelic Scottish Gaelic Serbian Serbian Sesotho Sesotho Shona Shona Sindhi Sindhi Sinhala Sinhala Slovak Slovak Slovenian Slovenian Somali Somali Spanish Spanish Sudanese Sudanese Swahili Swahili Swedish Swedish Tajik Tajik Tamil Tamil Telugu Telugu Thai Thai Turkish Turkish Ukrainian Ukrainian Urdu Urdu Uzbek Uzbek Vietnamese Vietnamese Welsh Welsh Xhosa Xhosa Yiddish Yiddish Yoruba Yoruba Zulu Zulu

Official Statement: CDC Director on Vaccine

Pfizer COVID-19 vaccine approved for use in European Union
covid vaccine allergic reaction

The United States achieved an early but important milestone today โ€“ jurisdictions have now reported that more than 1 million people have received their first dose of COVID-19 vaccine since administration began 10 days ago.

With cases of COVID-19 continuing to surge nationwide, this achievement comes at a critical time and will help to protect those on the frontlines โ€“ our healthcare providers treating COVID-19 patients โ€“ as well as our most vulnerable: elder individuals living in nursing homes and assisted living facilities.ย 

While we celebrate this historic milestone, we also acknowledge the challenging path ahead. There is currently a limited supply of COVID-19 vaccine in the U.S., but supply will increase in the weeks and months to come. The goal is for everyone to be able to easily get vaccinated against COVID-19 as soon as large enough quantities are available.

CDC, along with DoD and other federal partners, continues to work closely with state, local, tribal, and territorial health departments to combat the spread of COVID-19, and distribute COVID-19 vaccine doses as quickly as possible to accomplish vaccination of the American public. 

Vaccination is a critical tool in bringing this unprecedented pandemic to an end. But until every person in the U.S. is able to get a COVID-19 vaccine, we continue to ask Americans to embrace proven public health strategies including social distancing, good hand hygiene, and wearing a mask in public to reduce the risk of transmission and protect our communities. 

#rebuildingtravel